Analysis of Gene Polymorphisms in Benign Prostate Hyperplasia Patients Receiving Combination Therapy of Alpha Blocker (a-Blocker) and 5-Alpha Reductase Inhibitor (5-ARI).
Variations in genetic makeup significantly affect personalized medical care. Identification of specific SNPs such as rs61767072 may be the basis for the development of more personalized therapies. This study provides evidence that pharmacogenomic approaches are needed in urology practice to improve treatment outcomes.
Authors
- David Agustriawan (ORCID: https://orcid.org/0000-0003-1185-1145)
- Besut Daryanto (ORCID: https://orcid.org/0000-0002-0776-1633)
- Edvin Prawira Negara (ORCID: https://orcid.org/0000-0003-0702-1173)
- Widodo Widodo (ORCID: https://orcid.org/0000-0002-4564-2694)
- Taufiq Nur Budaya (ORCID: https://orcid.org/0000-0001-9644-6792)
- Reza Akbar Effendi
Institutions
- University of Brawijaya (ID)
Publication Details
- Journal
- PubMed
- Published
- 2025-01-01
- DOI
- https://doi.org/10.5455/aim.2024.33.54-57
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00